Citation: Bg. Xing et al., Binding properties of an orally active platinum anti-tumor drug JM216 withmetallothionein in vivo, BIOMETALS, 13(3), 2000, pp. 203-208
Authors:
Woldegiorgis, G
Shi, JY
Zhu, HF
Arvidson, DN
Citation: G. Woldegiorgis et al., Functional characterization of mammalian mitochondrial carnitine palmitoyltransferases I and II expressed in the yeast Pichia pastoris, J NUTR, 130(2), 2000, pp. 310S-314S
Citation: J. Dai et al., Identification by mutagenesis of conserved arginine and tryptophan residues in rat liver carnitine palmitoyltransferase I important for catalytic activity, J BIOL CHEM, 275(29), 2000, pp. 22020-22024
Authors:
Shi, JY
Zhu, HF
Arvidson, DN
Woldegiorgis, G
Citation: Jy. Shi et al., The first 28 N-terminal amino acid residues of human heart muscle carnitine palmitoyltransferase I are essential for malonyl CoA sensitivity and high-affinity binding, BIOCHEM, 39(4), 2000, pp. 712-717
Authors:
Shi, JY
Zhu, HF
Arvidson, DN
Woldegiorgis, G
Citation: Jy. Shi et al., A single amino acid change (substitution of glutamate 3 with alanine) in the N-terminal region of rat liver carnitine palmitoyltransferase I abolishes malonyl-CoA inhibition and high affinity binding, J BIOL CHEM, 274(14), 1999, pp. 9421-9426